Publication | Closed Access
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
82
Citations
17
References
2014
Year
Alfacalcidol is a safe and effective treatment strategy to decrease fatigue and improve QoL in patients with MS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1